MS Living Well Podcast. Harnessing AI: Transforming MS Care

Apr 9 2024

Prepare to be intrigued by the groundbreaking intersection of artificial intelligence (AI) and multiple sclerosis care! By combing through extensive databases, including genetic information and real patient records, AI can forecast with remarkable accuracy the likelihood of MS onset. In the near future, AI could even serve as a guiding light for clinicians and MS patients in selecting the most suitable disease-modifying therapies, armed with predictive algorithms tailored for each individual.

But the marvels of AI don’t stop there. In a recent study, AI detected an astonishing 93% of new and enlarging T2 brain lesions in MRI scans, far surpassing the 58% accuracy rate of routine radiology reads. Artificial intelligence is also making waves in drug development and early clinical trial design, accelerating the quest for innovative therapies to combat MS.

This podcast episode is sponsored by TG Therapeutics.

Barry Singer MD, Director of the MS Center for Innovations in Care, interviews:

Tal Arbel PhD

Tal Arbel PhD is a Professor in the Department of Electrical and Computer Engineering at McGill University in Montreal, Canada where she is the Director of the Probabilistic Vision Group and Medical Imaging Lab in the Centre for Intelligent Machines. She is a Canadian Institute for Advanced Research (CIFAR) AI Chair – MILA Montreal Institute for Learning Algorithms (MILA).  Her research focuses on development of deep learning methods in medical image analysis including detection of lesions in MRI images of MS patients and evaluating response to new MS treatments.

Michael Barnett MBBS (Hons) FRACP PhD

Michael Barnett MBBS (Hons) FRACP PhD is a consultant neurologist at Royal Prince Alfred Hospital Sydney, Professor in Neurology at the University of Sydney, and Director of the MS Society Clinic and MS Clinical Trials Unit at the Brain and Mind Centre. He trained in neurology at Royal Prince Alfred Hospital and received further subspecialty training at the National Hospital for Neurology and Neurosurgery in London. He subsequently completed a PhD in MS pathophysiology at the University of Sydney. Dr Barnett’s current research focus is neuroimaging applications in MS co-founded the Sydney Neuroimaging Analysis Centre in 2012. He is also Director of the MS Research Australia Brain Bank.

BY: Barry Singer, MD DATE: April 9, 2024 TOPIC: Podcasts